Balboa Wealth Partners lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 51.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,035 shares of the medical equipment provider's stock after selling 2,187 shares during the period. Balboa Wealth Partners' holdings in Intuitive Surgical were worth $1,000,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently added to or reduced their stakes in ISRG. Kingsview Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 1.2% in the 1st quarter. Kingsview Wealth Management LLC now owns 4,144 shares of the medical equipment provider's stock valued at $1,654,000 after purchasing an additional 51 shares during the last quarter. M&G Plc acquired a new stake in Intuitive Surgical during the first quarter valued at approximately $1,318,000. Nicolet Advisory Services LLC lifted its position in Intuitive Surgical by 24.6% in the 1st quarter. Nicolet Advisory Services LLC now owns 1,059 shares of the medical equipment provider's stock worth $414,000 after buying an additional 209 shares in the last quarter. Spirepoint Private Client LLC acquired a new position in shares of Intuitive Surgical during the 1st quarter worth $454,000. Finally, Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 1.6% in the 1st quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider's stock valued at $12,319,358,000 after purchasing an additional 493,126 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.
ISRG opened at $537.80 on Friday. The firm has a market cap of $191.55 billion, a P/E ratio of 86.46, a P/E/G ratio of 5.28 and a beta of 1.39. The business has a fifty day simple moving average of $496.95 and a 200-day simple moving average of $455.65. Intuitive Surgical, Inc. has a 52 week low of $291.39 and a 52 week high of $544.38.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.
In other news, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the transaction, the director now owns 821 shares of the company's stock, valued at approximately $402,519.88. This trade represents a 35.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of the firm's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the transaction, the senior vice president now directly owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 93.06 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock valued at $45,897,071 in the last quarter. 0.90% of the stock is currently owned by corporate insiders.
Several research firms have weighed in on ISRG. Leerink Partners raised their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Truist Financial increased their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a "buy" rating in a report on Monday, October 14th. Barclays increased their target price on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an "overweight" rating in a research report on Thursday, July 18th. Royal Bank of Canada raised their price objective on Intuitive Surgical from $525.00 to $555.00 and gave the company an "outperform" rating in a research note on Friday, October 18th. Finally, Robert W. Baird lifted their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. Based on data from MarketBeat.com, Intuitive Surgical has a consensus rating of "Moderate Buy" and an average price target of $513.74.
Get Our Latest Research Report on ISRG
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.